US panel recommends lifting pause on J&J's COVID-19 vaccine
Updated: 2021-04-24 05:41
Share
Share - WeChat
April 23 - Use of Johnson & Johnson's COVID-19 vaccine should be resumed in the United States as specified under its emergency use authorization by the US Food and Drug Administration, advisers to the US Centers for Disease Control and Prevention recommended on Friday.
Reuters
Most Viewed in 24 Hours
